(Q44544700)

4 December 2017

title

Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period (English)

1 reference

4 December 2017

Dimitrios S Goumenos

1

1 reference

4 December 2017

Sotiris Tsakas

2

1 reference

4 December 2017

Dionisios Karavias

3

1 reference

4 December 2017

Irini Savidaki

4

1 reference

4 December 2017

Thoedoros Karatzas

5

1 reference

4 December 2017

John G Vlachojannis

6

1 reference

4 December 2017

publication date

1 July 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

25

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

561-568

1 reference

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Delayed graft function in renal transplantation: etiology, management and long-term significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Expression of transforming growth factor-beta isoforms in human glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Altered expression of transforming growth factor-beta S in chronic renal rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Urinary transforming growth factor-beta 1 in membranous glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

Chronic renal allograft rejection: immunologic and nonimmunologic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022547

21 January 2018

Identifiers

DOI

10.1081/JDI-120022547

1 reference

4 December 2017

1 reference